Prosight Management as of Dec. 31, 2018
Portfolio Holdings for Prosight Management
Prosight Management holds 35 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Hanger Orthopedic | 11.6 | $23M | 1.2M | 18.95 | |
Reata Pharmaceuticals Inc Cl A | 7.3 | $14M | 253k | 56.10 | |
Cigna Corp (CI) | 7.2 | $14M | 73k | 189.92 | |
WellCare Health Plans | 6.1 | $12M | 50k | 236.10 | |
Arena Pharmaceuticals | 5.6 | $11M | 278k | 38.95 | |
Zimmer Holdings (ZBH) | 5.5 | $11M | 103k | 103.72 | |
Iovance Biotherapeutics (IOVA) | 4.8 | $9.4M | 1.1M | 8.85 | |
BioMarin Pharmaceutical (BMRN) | 4.5 | $8.8M | 103k | 85.15 | |
Allergan | 4.2 | $8.2M | 61k | 133.66 | |
Albireo Pharma | 3.4 | $6.6M | 270k | 24.53 | |
Assembly Biosciences | 3.2 | $6.2M | 276k | 22.62 | |
Galapagos Nv- (GLPG) | 3.0 | $5.8M | 63k | 91.74 | |
Intec Pharma | 2.6 | $5.1M | 676k | 7.54 | |
Teligent | 2.5 | $4.9M | 3.5M | 1.37 | |
On Assignment (ASGN) | 2.5 | $4.8M | 88k | 54.50 | |
Viking Therapeutics (VKTX) | 2.5 | $4.8M | 624k | 7.65 | |
Providence Service Corporation | 2.4 | $4.7M | 78k | 60.01 | |
Kura Oncology (KURA) | 2.3 | $4.4M | 317k | 14.04 | |
Axogen (AXGN) | 2.2 | $4.3M | 209k | 20.43 | |
Strongbridge Bioph shs usd | 2.2 | $4.2M | 938k | 4.48 | |
Catalyst Biosciences | 1.9 | $3.7M | 467k | 7.89 | |
Sierra Oncology | 1.7 | $3.4M | 2.6M | 1.32 | |
Aldeyra Therapeutics (ALDX) | 1.7 | $3.4M | 405k | 8.30 | |
Centene Corporation (CNC) | 1.5 | $2.9M | 25k | 115.32 | |
Macrogenics (MGNX) | 1.3 | $2.5M | 194k | 12.70 | |
Evolus (EOLS) | 1.2 | $2.3M | 196k | 11.90 | |
Millendo Therapeutics | 1.1 | $2.0M | 257k | 7.95 | |
Ligand Pharmaceuticals In (LGND) | 0.9 | $1.7M | 13k | 135.71 | |
Triple-S Management | 0.6 | $1.1M | 66k | 17.39 | |
Clovis Oncology | 0.6 | $1.1M | 60k | 17.95 | |
Cerecor | 0.5 | $994k | 308k | 3.23 | |
Pieris Pharmaceuticals | 0.5 | $885k | 333k | 2.66 | |
Optinose (OPTN) | 0.5 | $870k | 140k | 6.20 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $578k | 246k | 2.35 | |
Aquinox Pharmaceuticals | 0.1 | $173k | 80k | 2.15 |